Cargando…
Secondary Dyslipidemia In Obese Children - Is There Evidence For Pharmacological Treatment?
BACKGROUND: Long-term safety, effectiveness and criteria for treatment with statins in children are still unclear in clinical practice. There is very limited evidence for the use of medication to treat children with dyslipidemia secondary to obesity who do not respond well to lifestyle modification....
Autores principales: | Radaelli, Graciane, Sausen, Grasiele, Cesa, Claudia Ciceri, Portal, Vera Lucia, Pellanda, Lucia Campos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Cardiologia - SBC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173338/ https://www.ncbi.nlm.nih.gov/pubmed/30156604 http://dx.doi.org/10.5935/abc.20180155 |
Ejemplares similares
-
Statin Treatments And Dosages In Children With Familial
Hypercholesterolemia: Meta-Analysis
por: Radaelli, Graciane, et al.
Publicado: (2018) -
Effect of yerba mate and green tea on paraoxonase and leptin levels in patients affected by overweight or obesity and dyslipidemia: a randomized clinical trial
por: Balsan, Guilherme, et al.
Publicado: (2019) -
Secondary Dyslipidemia In Obese Children - Is There Evidence For
Pharmacological Treatment?
por: Tanaka, Ana Cristina Sayuri
Publicado: (2018) -
Overweight and obesity in children with congenital heart disease: combination of risks for the future?
por: Barbiero, Sandra Mari, et al.
Publicado: (2014) -
Early Markers of Atherosclerotic Disease in Individuals with Excess
Weight and Dyslipidemia
por: Menti, Eduardo, et al.
Publicado: (2016)